Ontology highlight
ABSTRACT: Patient summary
In men with prostate cancer with rising PSA levels following surgery and radiation, a newer type of scan called PSMA-PET (prostate-specific membrane antigen positron emission tomography) can be used to characterize and differentiate the patterns of recurrence, and inform future cancer outcomes.
SUBMITTER: Glicksman RM
PROVIDER: S-EPMC10240507 | biostudies-literature | 2023 Jun
REPOSITORIES: biostudies-literature
Glicksman Rachel M RM Murad Vanessa V Santiago Anna T AT Liu Zhihui Z Ramotar Matthew M Metser Ur U Berlin Alejandro A
European urology open science 20230502
We conducted and previously published a phase 2 trial of metastasis-directed therapy (MDT) in men with recurrence of prostate cancer at a low prostate-specific antigen level following radical prostatectomy and postoperative radiotherapy. All patients had negative conventional imaging and underwent prostate-specific membrane antigen (PSMA) positron emission tomography (PET). Patients without visible disease (<i>n</i> = 16) or with metastatic disease not amenable to MDT (<i>n</i> = 19) were exclud ...[more]